Home> Products> simple dosing regimen

{ "products": [ { "_id": "6a5df739c15b0b6844e869c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 20 mg", "description": "OLANZPRIME 20 is a 20 mg Olanzapine mouth-dissolving tablet used to manage schizophrenia and bipolar disorder, typically for patients whose psychiatrist has determined a higher dose is appropriate than the standard 15 mg strength. It calms overactive dopamine and serotonin signaling in the brain, easing hallucinations, delusions, and mood instability. The tablet dissolves on the tongue in seconds, so no water is needed — a practical advantage for elderly patients or anyone who struggles with swallowing. Because higher-dose Olanzapine carries a somewhat greater chance of metabolic side effects like weight gain, regular monitoring is often advised. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 20 Price – Olanzapine 20mg MD Tablet (Recommended)\nOLANZPRIME 20mg – Mouth Dissolving Antipsychotic\nOLANZPRIME 20 Price – Higher-Dose Olanzapine MD\nOlanzapine 20mg MD Tablet – OLANZPRIME Price Online\nOLANZPRIME 20 – Schizophrenia & Bipolar MD Tablet\n\nRationale: Option 1 leads with the “Price” anchor required for this Schedule H product and specifies the 20 mg strength clearly, helping differentiate it in search from the 15 mg SKU while staying within character limits.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 20 delivers higher-dose Olanzapine in an MD tablet for schizophrenia & bipolar care. Check price online. Prescription only – doctor advised.\n\nFull CMS Article\nOLANZPRIME 20: Higher-Strength Olanzapine Mouth Dissolving Tablet for Psychiatric Care\nTL;DR / AI Mode Summary\n\nOLANZPRIME 20 provides Olanzapine at a 20 mg strength in a fast-dissolving tablet form, prescribed for schizophrenia, bipolar disorder, and related conditions where a psychiatrist determines a higher dose is clinically needed. Like other Olanzapine formulations, it works on dopamine and serotonin pathways to steady mood and reduce psychotic symptoms. The dissolving format skips the need for water, which helps with adherence in patients who find tablet-swallowing difficult. Given the higher strength, monitoring for metabolic changes — weight, blood sugar, lipids — is a routine part of long-term care.\n\nUnderstanding OLANZPRIME 20\n\nNot every patient responds the same way to a starting dose of Olanzapine. Where symptoms remain inadequately controlled at lower strengths, or where a psychiatrist's clinical judgment calls for a higher therapeutic level, OLANZPRIME 20 offers the 20 mg strength in the same convenient mouth-dissolving format — sparing patients the need to switch to swallowing multiple lower-strength tablets or handle water-based dosing.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 20\nActive Ingredient\tOlanzapine\nStrength\t20 mg\nForm\tMouth Dissolving Tablet (MD)\nRoute\tOral\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nConditions It's Prescribed For\nSchizophrenia\nBipolar I Disorder, including acute manic episodes\nLong-term maintenance care for bipolar disorder\nPsychotic disorders more broadly\nMood disorders, at a psychiatrist's discretion\nAgitation linked to certain psychiatric presentations\n\nThe aim across these conditions is the same: dial down hallucinations, delusions, and disorganized thought enough that patients can re-engage with daily routines and relationships.\n\nMechanism of Action\n\nSymptoms like hallucinations, mood swings, and confused thinking are strongly linked to overactive dopamine (D2) receptor signaling, along with disrupted serotonin (5-HT2A) activity in the brain.\n\nAt the 20 mg strength, Olanzapine:\n\nBlocks excess dopamine receptor activity more fully than lower doses may achieve\nModulates serotonin signaling alongside dopamine\nEases hallucinations, delusions, and anxiety tied to psychotic symptoms\nSupports steadier mood and reduced aggression\nHelps restore clearer, more organized thinking\n\nThe mouth-dissolving format means the tablet breaks down on the tongue within moments, which is particularly useful for elderly patients or anyone managing swallowing difficulty alongside their psychiatric condition.\n\nDirections for Use\nTake OLANZPRIME 20 only in the dose and frequency your psychiatrist prescribes — do not self-adjust to a higher or lower strength.\nPlace the tablet on the tongue and let it dissolve fully without chewing.\nSwallow once dissolved; water isn't usually necessary.\nTake it at a consistent time each day.\nComplete the full course your doctor recommends, even if you start feeling better.\nNever stop abruptly — sudden discontinuation can trigger symptom relapse or withdrawal-type effects.\nPossible Side Effects\n\nCommon, generally manageable effects include:\n\nDrowsiness or sleepiness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nDizziness\nFatigue\nTremors\nRestlessness\n\nLess common but more serious effects can include severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of elevated blood sugar. Because the 20 mg strength is a higher dose, these metabolic and neurological effects warrant closer attention.\n\nPlaceholder: incidence rates and dose-comparison trial data pending qualified clinical reviewer sign-off before publication.\n\nSeek emergency care immediately if any of these serious symptoms appear.\n\nWho Should Be Cautious\n\nShare your full medical history with your doctor before starting, especially if you have:\n\nDiabetes or a family history of diabetes\nLiver or kidney disease\nHeart disease\nHigh cholesterol or triglycerides\nEpilepsy or seizure disorders\nGlaucoma\nParkinson's disease\nDementia, particularly in older patients\nA prior stroke\nPrecautions & Lifestyle Considerations\nAvoid alcohol, since it can compound drowsiness.\nBe cautious with driving or operating machinery until you know how the medicine affects you.\nBecause Olanzapine — especially at higher strengths — can contribute to weight gain, a balanced diet and regular activity are worth building into your routine.\nLong-term treatment typically includes periodic checks of blood sugar, lipid levels, and body weight.\nIn pregnancy or while breastfeeding, use only if your doctor has weighed the benefits against potential risks.\nStorage Instructions\nStore below 25°C, protected from moisture, heat, and direct sunlight.\nKeep tablets in the original blister pack until the moment of use.\nKeep out of reach of children.\nDo not use past the expiry date printed on the pack.\nComparing Olanzapine Strengths\nStrength\tTypical Scenario\tConsiderations\nOLANZPRIME 15 (15 mg)\tStandard starting or maintenance dose\tSuitable for many patients as an initial therapeutic level\nOLANZPRIME 20 (20 mg)\tHigher therapeutic need per psychiatrist's assessment\tMay carry a somewhat greater likelihood of metabolic side effects; monitoring emphasized\n\nNote: The right strength is determined entirely by a psychiatrist's clinical assessment — patients should never switch strengths on their own.\n\nWhy Choose OLANZPRIME 20?\n\nFor patients who need a higher Olanzapine dose but still benefit from a swallow-free administration route, OLANZPRIME 20 combines both. It's manufactured to consistent pharmaceutical quality standards, giving psychiatrists, hospitals, and pharmacies a dependable higher-strength option without sacrificing the ease-of-use that mouth-dissolving tablets are known for.\n\nConclusion\n\nManaging schizophrenia or bipolar disorder sometimes calls for a higher Olanzapine dose than a standard starting regimen provides. OLANZPRIME 20 delivers that strength in a mouth-dissolving format that keeps daily administration simple, even for patients who find conventional tablets difficult to manage. Taken consistently under a psychiatrist's supervision, with regular monitoring for metabolic changes, it supports steadier, more manageable day-to-day functioning. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 20 used for? It's prescribed for schizophrenia, bipolar disorder, and other psychiatric conditions where a psychiatrist determines this higher strength is appropriate.\nHow is OLANZPRIME 20 different from OLANZPRIME 15? Both contain Olanzapine in the same mouth-dissolving format; OLANZPRIME 20 is a higher 20 mg strength used when a psychiatrist assesses that a greater dose is clinically needed.\nHow should I take it? Place the tablet on your tongue, let it dissolve fully, and swallow naturally — always following your doctor's exact dosing.\nDo I need water to take this tablet? No, it's designed to dissolve on the tongue without water.\nCan OLANZPRIME 20 cause weight gain? Yes, weight gain and increased appetite are known effects, and the risk may be somewhat higher at this strength — regular monitoring and healthy habits can help manage it.\nIs this strength safe for long-term use? Yes, under a psychiatrist's ongoing supervision, with periodic checks of weight, blood sugar, and lipid levels.\nCan I switch from OLANZPRIME 15 to OLANZPRIME 20 on my own? No — any change in strength must be directed by your prescribing psychiatrist.\nWhat happens if I stop taking it suddenly? Stopping abruptly can lead to symptom relapse or withdrawal-type effects; any discontinuation should be gradual and doctor-guided.\nDoes alcohol interact with OLANZPRIME 20? Yes, alcohol can intensify drowsiness and should generally be avoided during treatment.\nIs it safe to drive while taking this medicine? Use caution with driving or operating machinery until you understand how the medicine affects your alertness and coordination.\nWhat health conditions should I disclose before starting? Mention diabetes, liver or kidney disease, heart disease, high cholesterol, epilepsy, glaucoma, Parkinson's disease, dementia, or a history of stroke.\nWhat serious symptoms need immediate medical attention? Severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of very high blood sugar require urgent care.\nCan this be used during pregnancy? Only under medical supervision, after your doctor weighs the potential benefits against risks.\nIs a prescription required to buy OLANZPRIME 20? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.\nHow long until I notice improvement? This varies by individual and condition; your psychiatrist will track progress through scheduled follow-ups.\n\n[Steris Healthcare Footer] Manufactured and marketed by Steris Healthcare Pvt. Ltd. — a WHO-GMP and ISO-certified pharmaceutical manufacturer. For queries, reach us at contact@sterispharma.com or +91 8824175417. This content is for informational purposes only and does not replace professional medical advice. Prescription only – consult your doctor.", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2479, "imageuri": "https://productimages.withfloats.com/actual/6a5df73c6c57d63669881829.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df73c6c57d63669881829.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:23:53.814Z", "updatedon": "2026-07-20T10:23:53.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/olanzapine-mouth-dissolving-tablets-20-mg/2479", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 20", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5de55aa467a7e64774de83", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Teneligliptin 20mg,Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets", "description": "TENELIGOLD PM 1000 brings together three antidiabetic agents — Teneligliptin 20 mg, Pioglitazone 15 mg, and Metformin Hydrochloride (Sustained Release) 1000 mg — in a single tablet built to support glycemic control in adults living with Type 2 Diabetes Mellitus (T2DM). Rather than relying on one pathway, this triple-action formula addresses blood glucose from several angles at once, offering a more rounded approach to sugar management.\n\nProduced under strict pharmaceutical quality benchmarks, TENELIGOLD PM 1000 works to sharpen the body's response to insulin, prompt insulin release in step with rising glucose, and rein in the liver's excess sugar output. It's typically brought into a treatment plan once lifestyle changes and single-drug therapy no longer keep blood sugar within target range.\n\nComposition\n\nEach sustained-release tablet delivers:\n\nTeneligliptin – 20 mg\nPioglitazone – 15 mg\nMetformin Hydrochloride (Sustained Release) – 1000 mg\n\nDosage Form: Sustained Release Tablets\n\nHow TENELIGOLD PM 1000 Works\n\nThis tablet pairs three well-known antidiabetic molecules so their effects complement one another.\n\n1. Teneligliptin 20 mg\n\nA DPP-4 inhibitor, Teneligliptin raises the body's incretin hormone activity, which in turn:\n\nTriggers insulin output only when glucose levels are elevated\nCurbs glucagon release\nFlattens the post-meal blood sugar rise\nKeeps hypoglycemia risk low\n\n2. Pioglitazone 15 mg\n\nBelonging to the Thiazolidinedione (TZD) family, Pioglitazone:\n\nSharpens the body's sensitivity to insulin\nHelps muscle tissue take up and use glucose more effectively\nCuts down insulin resistance\nAids sustained glycemic management over time\n\n3. Metformin SR 1000 mg\n\nA Biguanide-class agent, Metformin SR:\n\nSlows the liver's glucose output\nLimits how much glucose the intestines absorb\nBoosts insulin responsiveness\nDelivers steady blood sugar control across the day\n\nBecause it's released gradually, the sustained-release format is also gentler on the stomach than immediate-release versions.\n\nBenefits of TENELIGOLD PM 1000\n\nWell-Rounded Blood Sugar Control The three-pronged formula works to steady both fasting glucose and the spikes that follow meals.\n\nStronger HbA1c Improvement Used appropriately, this combination therapy may lower HbA1c more than a single-agent approach would.\n\nSharper Insulin Response Pioglitazone's role in easing insulin resistance means the insulin the body produces (or receives) does more work.\n\nSteady, All-Day Coverage Metformin SR's gradual release keeps blood sugar levels more consistent throughout the day.\n\nOne Tablet, Three Medicines Combining proven antidiabetic drugs into a single pill can make treatment simpler and support better adherence.\n\nA Foundation for Long-Term Care Sustained glycemic control, paired with healthy lifestyle habits, may help lower the risk of diabetes-related complications down the line.\n\nIndications\n\nTENELIGOLD PM 1000 is intended as an add-on to diet and exercise for improving blood sugar control in adults with Type 2 Diabetes Mellitus, particularly where a physician determines combination therapy is the right course.\n\nIt is not meant for Type 1 Diabetes Mellitus or diabetic ketoacidosis.\n\nKey Features\nTriple-combination antidiabetic tablet\nSustained-release Metformin component\nSupports both fasting and post-meal glucose control\nImproves insulin sensitivity\nEncourages glucose-responsive insulin release\nLowers hepatic glucose output\nOnce-daily dosing convenience, as prescribed\nManufactured to rigorous quality standards\nSuited to long-term diabetes management under medical guidance\nWho May Benefit?\n\nPhysicians may consider TENELIGOLD PM 1000 for adult T2DM patients who:\n\nContinue to have unmanaged blood sugar despite two-drug therapy\nNeed better HbA1c outcomes\nShow marked insulin resistance\nRequire broader glycemic coverage\nWould benefit from a sustained-release metformin option\n\nEvery treatment decision should be tailored by the prescribing doctor.\n\nDirections for Use\nTake exactly as directed by your physician.\nSwallow the tablet whole with water.\nNever crush, chew, or split the sustained-release tablet.\nTaking it with food is generally advised to ease stomach upset.\nPair the medicine with your prescribed diet and exercise plan for best results.\nPossible Side Effects\n\nAs with any medicine, TENELIGOLD PM 1000 can cause side effects, though not everyone will experience them.\n\nCommonly reported:\n\nNausea\nDiarrhea\nStomach discomfort\nHeadache\nSlight weight gain\nSwelling in the extremities (peripheral edema), linked mainly to pioglitazone\n\nLess common but serious:\n\nLactic acidosis (a metformin-related risk, more likely in vulnerable patients)\nWorsening heart failure (associated with pioglitazone in select patients)\nAllergic reactions\nAbnormal liver function\n\nSeek urgent medical care if severe weakness, breathing difficulty, chest pain, or ongoing abdominal pain develops.\n\nPrecautions\n\nTell your healthcare provider before starting TENELIGOLD PM 1000 if you have any of the following:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer, present or past\nPancreatitis\nVitamin B12 deficiency\nSevere dehydration\nAn upcoming surgery or imaging test involving iodinated contrast dye\n\nRoutine checks of blood glucose, HbA1c, kidney function, liver function, and related markers are advised throughout treatment.\n\nStorage Instructions\nStore below 30°C.\nKeep away from moisture and direct sunlight.\nLeave in the original packaging.\nStore out of children's reach.\nWhy Choose TENELIGOLD PM 1000?\n\nTENELIGOLD PM 1000 brings three established antidiabetic medicines together in one sustained-release tablet, giving physicians a way to simplify a patient's regimen while still addressing multiple facets of Type 2 Diabetes. Through its complementary mechanisms, it offers a well-rounded route to blood sugar control for suitably selected adult patients under medical supervision.\n\nFrequently Asked Questions (FAQs)\n\nWhat is TENELIGOLD PM 1000 used for? It's prescribed to help manage Type 2 Diabetes Mellitus in adults whose blood sugar needs combination therapy alongside diet and exercise.\n\nIs TENELIGOLD PM 1000 meant to be taken every day? Yes, exactly as your physician prescribes. Don't adjust the dose on your own.\n\nCan TENELIGOLD PM 1000 lead to low blood sugar? Taken alone, the hypoglycemia risk is generally low, though it can rise if combined with insulin or sulfonylureas.\n\nCan I stop the medicine once my sugar levels normalize? No — diabetes is a long-term condition. Keep taking the medicine unless your doctor says otherwise.\n\nIs this medicine right for Type 1 Diabetes? No. It's formulated only for adults with Type 2 Diabetes Mellitus.\n\nShould TENELIGOLD PM 1000 be taken with food? Yes, taking it with meals is generally recommended to reduce stomach-related side effects.\n\nDoes it help bring down HbA1c? Yes — used as directed alongside lifestyle changes, it can support meaningful HbA1c improvement.\n\nPrescription only – consult your doctor.\n\n", "price": 385.0, "discountamount": 95.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2473, "imageuri": "https://productimages.withfloats.com/actual/6a5de55cdc76c6268e3fe287.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5de55cdc76c6268e3fe287.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T09:07:38.732Z", "updatedon": "2026-07-20T09:07:38.732Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligliptin-20mg-pioglitazone-15mg-metformin-hydrochloride-sustained-release-1000mg-tablets/2473", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a50a78a75263abd944f583a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Loteprednol Etabonate Ophthalmic Suspension", "description": "Loteprednol etabonate ophthalmic suspension is a prescription corticosteroid eye drop used to treat steroid-responsive inflammatory conditions of the eye, including post-surgical inflammation, allergic conjunctivitis, and certain forms of anterior uveitis. What sets loteprednol apart from older ophthalmic steroids is its “ester-based” chemical structure, which is designed to break down into inactive components after acting on eye tissue — giving it a comparatively lower risk of raising intraocular pressure (IOP) than traditional steroids like prednisolone or dexamethasone, while still delivering effective anti-inflammatory action. The typical dose is one to two drops in the affected eye, four times daily, or as directed, usually for a short, defined course rather than indefinite use. Common side effects include burning, stinging, and blurred vision, while prolonged or unsupervised use can still carry steroid-related risks such as elevated eye pressure. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Loteprednol Etabonate Ophthalmic Suspension?\nLoteprednol etabonate ophthalmic suspension is a topical corticosteroid formulated specifically for use in the eye. It belongs to a category sometimes referred to as “site-specific” or “soft” steroids — a design approach where the drug is engineered to be highly active at the site of application (the eye) but rapidly metabolized into inactive by-products once it has acted, reducing the potential for the cumulative steroid-related side effects seen with older ophthalmic corticosteroids.\nThis suspension is commonly prescribed for:\n\nManaging inflammation following eye surgery, such as cataract surgery\nTreating allergic conjunctivitis, including seasonal allergic conjunctivitis\nCertain anterior segment inflammatory conditions, such as uveitis, under specialist supervision\nGiant papillary conjunctivitis and other steroid-responsive ocular surface conditions\n\nBecause of its comparatively favorable IOP profile, loteprednol is often considered by ophthalmologists for patients who need effective anti-inflammatory therapy but may be at higher risk from more potent steroids — though it is important to note that no ophthalmic steroid is entirely free of IOP-related risk, and monitoring remains necessary.\n\nHow Does Loteprednol Etabonate Work? (Mechanism of Action)\n\nCorticosteroid receptor binding – Loteprednol etabonate binds to glucocorticoid receptors within ocular tissue, initiating anti-inflammatory gene expression changes.\nSuppression of inflammatory mediators – This binding reduces the production of key inflammatory substances, including prostaglandins and cytokines, that drive redness, swelling, and discomfort.\nReduced vascular permeability – By calming the inflammatory cascade, the drug helps reduce leakage of fluid and inflammatory cells into ocular tissue, easing swelling.\nEster-based metabolism – Unlike ketone-based steroids, loteprednol's ester structure allows ocular esterases to break it down into inactive metabolites after it exerts its effect, which is thought to underlie its comparatively lower propensity to raise intraocular pressure.\nLocalized anti-inflammatory effect – The net result is effective control of ocular surface and anterior segment inflammation with a more favorable safety profile than some older steroid formulations, when used for the intended short duration.\n\n\nClinical Indications\nIndicationDetailsPost-operative ocular inflammationCommon after cataract and other intraocular surgeriesAllergic conjunctivitisIncluding seasonal allergic conjunctivitisGiant papillary conjunctivitisOften associated with contact lens wearAnterior uveitisUnder specialist supervisionOther steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segmentAs directed by an ophthalmologist\nNot indicated for: viral (e.g., herpes simplex), fungal, or mycobacterial eye infections, where corticosteroid use can worsen the underlying condition.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye(s), typically 4 times dailyPost-surgical regimenOften started at higher frequency and tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationShort, defined course as prescribed; not intended for indefinite useTaperingGradual reduction recommended rather than abrupt discontinuation after extended useContact lensesRemove before instillation; reinsert only per your doctor's adviceMissed doseApply as soon as remembered; do not double the next dose\nImportant: Even with its comparatively favorable safety profile, loteprednol should be used strictly for the duration prescribed. Extended, unsupervised use is not recommended.\n\nKey Benefits\n\nEffective anti-inflammatory action for a range of steroid-responsive ocular conditions\nEster-based design associated with a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids\nUseful for patients needing steroid therapy who may be more sensitive to IOP elevation, under appropriate monitoring\nSuitable for both post-surgical inflammation control and allergic conjunctivitis management\nAvailable in a suspension formulation designed for good ocular surface contact\nOften used as part of a short, defined treatment course, reducing exposure duration compared to continuous long-term steroid regimens\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nEven with its favorable profile, prolonged use can still raise intraocular pressure in susceptible individuals — periodic IOP monitoring is recommended\nExtended use may increase the risk of cataract formation, as with other ophthalmic steroids\nMay mask signs of infection or delay wound healing if used inappropriately\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation on instillation\nBlurred vision immediately after application\nEye discomfort or a foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nElevated intraocular pressure (comparatively less frequent than with older steroids, but still possible)\nDelayed wound healing\nSigns of secondary or masked ocular infection\nCataract progression with prolonged use\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist promptly if any serious symptom develops.\n\nComparison: Loteprednol vs. Other Ophthalmic Corticosteroids\nTreatmentClassIOP Risk ProfileBest Suited ForLoteprednol etabonate suspensionEster-based (“soft”) corticosteroidComparatively lowerPatients needing effective anti-inflammatory action with reduced IOP concernPrednisolone acetateKetone-based corticosteroidHigher with prolonged useRobust anti-inflammatory action; requires closer IOP monitoringDexamethasoneKetone-based corticosteroidHigher, potent effectSevere inflammatory conditions; typically shorter coursesFluorometholoneKetone-based corticosteroidModerateMild to moderate inflammation with somewhat reduced IOP risk\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported incidence of clinically significant IOP elevation with short-course loteprednol use[Placeholder – insert verified clinical trial statistic]Comparative IOP-elevation rate vs. prednisolone acetate in controlled studies[Placeholder – insert verified reference]Typical duration of post-operative loteprednol therapy[Placeholder – insert reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Loteprednol Etabonate Ophthalmic Suspension\nThe price of loteprednol etabonate ophthalmic suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nLoteprednol etabonate ophthalmic suspension offers a valuable option for managing steroid-responsive ocular inflammation — from post-surgical recovery to allergic conjunctivitis — with a design intended to reduce the intraocular pressure risks historically associated with ophthalmic corticosteroids. While its ester-based structure gives it a comparatively favorable safety profile, it remains a steroid, and prolonged or unsupervised use can still carry risks such as elevated eye pressure, cataract progression, and delayed healing. For this reason, loteprednol should always be used for the specific duration prescribed, with appropriate tapering and regular ophthalmic follow-up, rather than as a long-term, self-managed therapy.\n\nFrequently Asked Questions\n\n1. What is loteprednol etabonate ophthalmic suspension used for?\nIt is used to treat steroid-responsive eye inflammation, including inflammation after eye surgery, allergic conjunctivitis, and certain anterior segment inflammatory conditions such as uveitis, under an ophthalmologist's guidance.\n\n2. Is loteprednol a steroid?\nYes, loteprednol etabonate is a corticosteroid. It is specifically designed with an ester-based structure intended to reduce the risk of raising intraocular pressure compared to some older ophthalmic steroids, though it still requires medical supervision.\n\n3. How long can I use loteprednol eye drops?\nLoteprednol is typically prescribed for a short, defined course as determined by your ophthalmologist, often with a tapering schedule. It is not intended for indefinite, unsupervised long-term use.\n\n4. Does loteprednol raise eye pressure?\nLoteprednol has a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids due to its ester-based design, but it can still cause elevated eye pressure in susceptible individuals, especially with prolonged use, so periodic monitoring is recommended.\n\n5. Can loteprednol cause cataracts?\nProlonged use of any ophthalmic corticosteroid, including loteprednol, can increase the risk of cataract formation, particularly posterior subcapsular cataracts, which is why short, supervised courses are recommended.\n\n6. How is loteprednol different from prednisolone acetate?\nLoteprednol has an ester-based chemical structure designed to break down into inactive components after acting on the eye, which is associated with a lower risk of raising intraocular pressure compared to prednisolone acetate, a ketone-based steroid with a higher IOP-elevation potential.\n\n7. Can loteprednol be used for allergic conjunctivitis?\nYes, loteprednol etabonate ophthalmic suspension is commonly used to manage allergic conjunctivitis, including seasonal allergic conjunctivitis, especially when symptoms are significant or not controlled by other treatments.\n\n8. Is loteprednol safe after cataract surgery?\nYes, loteprednol is frequently prescribed to manage post-operative inflammation following cataract surgery, typically as part of a tapering regimen directed by the operating ophthalmologist.\n\n9. Can loteprednol be used for viral eye infections?\nNo, loteprednol and other corticosteroids are not appropriate for viral eye infections such as herpes simplex keratitis, as steroids can worsen these conditions if used inappropriately.\n\n10. What are the common side effects of loteprednol eye drops?\nCommon side effects include burning or stinging upon application, temporary blurred vision, mild eye redness, and eye discomfort. These are usually mild and resolve quickly.\n11. Does loteprednol need to be shaken before use?\nYes, since it is a suspension, the bottle should be shaken well before each use to ensure the medication is evenly distributed.\n\n12. Can loteprednol be stopped suddenly?\nStopping abruptly, especially after extended use, is generally not recommended. A gradual tapering schedule, as advised by your ophthalmologist, helps prevent rebound inflammation.\n\n13. Is loteprednol safe for long-term daily use?\nNo, loteprednol is generally intended for short, supervised courses rather than continuous long-term daily use, due to steroid-related risks with prolonged exposure.\n\n14. Can contact lenses be worn while using loteprednol?\nIt's generally recommended to remove contact lenses before applying loteprednol and reinsert them only after the interval advised by your doctor.\n\n15. Who should avoid using loteprednol eye drops?\nPatients with active untreated viral, fungal, or mycobacterial eye infections, or known hypersensitivity to the medication, should avoid loteprednol unless specifically directed otherwise by their ophthalmologist.\n\n16. Can loteprednol be used in children?\nUse in children should only occur under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n17. Does loteprednol cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.", "price": 150.0, "discountamount": 45.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2471, "imageuri": "https://productimages.withfloats.com/actual/6a50a78cd95cad00a915a6d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50a78cd95cad00a915a6d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T08:04:26.663Z", "updatedon": "2026-07-10T08:04:26.663Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//loteprednol-etabonate-ophthalmic-suspension/2471", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION LOPEDIUM 0.5%", "category": "Opthalmology Range", "tags": [ "Loteprednol Etabonate Ophthalmic Suspension", "loteprednol etabonate ophthalmic suspension uses", "loteprednol etabonate ophthalmic suspension uses in hindi", "loteprednol etabonate ophthalmic suspension in hindi", "loteprednol etabonate ophthalmic suspension eye drops uses", "loteprednol etabonate ophthalmic suspension eye drops", "loteprednol etabonate ophthalmic suspension use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a509bf6f44be736283180cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gatifloxacin & prednisolone acetate ophthalmic suspension", "description": "Gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription combination eye medicine that pairs a fourth-generation fluoroquinolone antibiotic (gatifloxacin) with a corticosteroid (prednisolone acetate) in a single formulation. It is used to treat steroid-responsive ocular inflammation where there is also a risk of, or existing, bacterial eye infection — most commonly after cataract or other ocular surgery, and in certain inflammatory eye conditions requiring both anti-infective and anti-inflammatory action together. Gatifloxacin fights the bacteria, while prednisolone acetate reduces inflammation, redness, and swelling. This combination is not the same as a plain antibiotic drop — because it contains a steroid, it requires closer monitoring, a defined tapering schedule, and should never be self-prescribed or used beyond the duration your ophthalmologist recommends. It is a Schedule H prescription-only medicine in India, commonly marketed under brand names such as Gatiquin P.\n\nWhat Is Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension?\nGatifloxacin and prednisolone acetate ophthalmic suspension is a fixed-dose combination eye drop that brings together two distinct classes of medication in one bottle:\n\nGatifloxacin — a fourth-generation fluoroquinolone antibiotic effective against a broad range of gram-positive and gram-negative bacteria commonly implicated in ocular infections.\nPrednisolone acetate — a corticosteroid that suppresses inflammation, swelling, and associated redness or discomfort in the eye.\n\nThis combination is typically prescribed when a clinician determines that an eye condition involves both active or potential bacterial infection and significant inflammation — a situation where using either drug alone would be insufficient. The most frequent use case is post-operative care following ocular surgery, such as cataract extraction, where inflammation control speeds recovery while the antibiotic component guards against surgical-site infection.\nA commonly recognized branded version of this combination in the Indian market is Gatiquin P, and patients often search specifically for this brand name alongside the generic combination name.\n\nHow Does This Combination Work? (Mechanism of Action)\n\nAntibacterial action (Gatifloxacin) – Gatifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to replicate their DNA, resulting in bactericidal activity against susceptible organisms.\nAnti-inflammatory action (Prednisolone acetate) – Prednisolone acetate suppresses the inflammatory cascade by inhibiting phospholipase A2 and reducing the release of inflammatory mediators, which decreases swelling, redness, and discomfort.\nCombined surgical/inflammatory coverage – Together, the two components address both the infective and inflammatory components of a single ocular condition, which is particularly useful in the immediate post-surgical period when both risks are elevated simultaneously.\nLocalized ocular delivery – As a topical suspension, the combination acts directly at the site of application, minimizing systemic absorption compared to oral antibiotics or steroids.\n\n\nClinical Indications\nIndicationDetailsPost-operative inflammation with infection riskMost common use — following cataract surgery or other intraocular proceduresSteroid-responsive inflammatory ocular conditionsWhere a bacterial infection is present or risk is significantChronic anterior uveitis with secondary infection riskUsed under specialist supervisionBlepharoconjunctivitis with inflammatory componentWhen combined anti-infective and anti-inflammatory action is clinically indicated\nNot indicated for: viral eye infections (e.g., herpes simplex keratitis), fungal eye infections, mycobacterial infections, or uncomplicated bacterial conjunctivitis without an inflammatory component — a steroid is not appropriate in these settings.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye, typically 4 times daily, or as directedPost-surgical regimenOften started with a higher frequency and gradually tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationDetermined by your ophthalmologist; steroid-containing drops are not for indefinite useTaperingMust be tapered gradually rather than stopped abruptly, especially after prolonged useContact lensesAvoid wearing contact lenses during treatment unless your doctor advises otherwiseMissed doseApply as soon as remembered; do not double the next dose\nImportant: Never extend use beyond the prescribed duration or restart the medication without consulting your ophthalmologist, as prolonged steroid exposure carries specific ocular risks (see Precautions below).\n\nKey Benefits\n\nProvides dual-action therapy — infection control and inflammation control — in a single formulation\nReduces the need for two separate eye drop regimens after surgery, simplifying the treatment schedule\nSpeeds resolution of post-surgical redness, swelling, and discomfort while covering infection risk\nBroad-spectrum antibacterial coverage from a fourth-generation fluoroquinolone\nCommonly trusted and prescribed by ophthalmic surgeons as part of standard post-operative protocols\nAvailable in a suspension formulation designed for effective ocular surface contact time\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nLong-term or unsupervised steroid use can raise intraocular pressure (IOP) and increase glaucoma risk\nProlonged use may increase the risk of posterior subcapsular cataract formation\nSteroid component may mask signs of a worsening infection or delay wound healing if misused\nRegular monitoring of intraocular pressure is recommended with extended use\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nTransient burning or stinging on instillation\nBlurred vision immediately after application\nEye discomfort or foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nIncreased intraocular pressure / glaucoma symptoms (eye pain, halos around lights)\nDelayed wound healing at a surgical site\nSecondary or masked ocular infection\nSigns of cataract progression with prolonged use\nCorneal or scleral thinning (rare, with extended steroid exposure)\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist immediately if any serious symptom develops.\n\nComparison: Combination vs. Standalone Therapies\nTreatmentCompositionBest Suited ForKey ConsiderationGatifloxacin + Prednisolone acetate suspensionAntibiotic + steroidPost-surgical care; infection + inflammation togetherRequires tapering; steroid monitoring neededGatifloxacin eye drops (alone)Antibiotic onlyUncomplicated bacterial conjunctivitis/keratitisNo steroid-related risk, but no anti-inflammatory actionPrednisolone acetate eye drops (alone)Steroid onlyNon-infectious inflammatory conditions (e.g., uveitis)Not appropriate if active infection is presentPlain lubricant/antibiotic-only regimensVariesMild post-op cases without significant inflammationMay be insufficient for higher-risk surgical cases\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported post-operative infection rate reduction with prophylactic use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery combination therapy[Placeholder – insert verified reference range]Incidence of steroid-induced IOP elevation with short-course use[Placeholder – insert epidemiological reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension\nThe price of this combination suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nGatifloxacin and prednisolone acetate ophthalmic suspension serves an important clinical role wherever bacterial infection risk and ocular inflammation occur together — most notably in the sensitive period following eye surgery. By combining a potent fourth-generation antibiotic with a well-established corticosteroid, this formulation streamlines post-operative and steroid-responsive inflammatory care into a single, clinician-directed regimen. Because the steroid component carries specific long-term risks — including elevated eye pressure, cataract progression, and delayed healing if misused — this medication should always be used exactly as prescribed, for the duration recommended, and with appropriate tapering and follow-up. Patients should never self-adjust dosing or extend use without their ophthalmologist's explicit guidance.\n\nFrequently Asked Questions\n\n1. What is Gatifloxacin and prednisolone acetate ophthalmic suspension used for?\nIt is used to treat eye conditions that involve both inflammation and a risk of bacterial infection — most commonly after eye surgery such as cataract surgery, where it reduces post-operative swelling and redness while protecting against infection.\n\n2. Is Gatifloxacin eye drops safe for children?\nGatifloxacin eye drops are generally considered usable in children for appropriate bacterial eye infections under a pediatric ophthalmologist's guidance. However, the gatifloxacin-prednisolone combination includes a steroid, which requires closer specialist supervision in children due to potential effects on eye pressure and healing, so it should only be used if specifically prescribed for a child.\n\n3. What is Gatifloxacin and prednisolone acetate ophthalmic suspension (Gatiquin P) used for?\nGatiquin P is a branded formulation of gatifloxacin and prednisolone acetate ophthalmic suspension. It is used for the same core purpose — managing post-surgical or steroid-responsive ocular inflammation where there is also a bacterial infection risk, most often following cataract or other intraocular surgery.\n\n4. Is prednisolone acetate safe for eyes?\nPrednisolone acetate is a corticosteroid that is generally safe for eyes when used exactly as prescribed and for the recommended duration under an ophthalmologist's supervision. However, unsupervised or prolonged use can raise intraocular pressure, increase glaucoma risk, contribute to cataract formation, and delay wound healing, so it should never be used without medical guidance or beyond the prescribed course.\n\n5. How is this eye drop different from regular antibiotic eye drops?\nRegular antibiotic eye drops only target bacteria, while this combination also contains a steroid to control inflammation. This dual action is useful specifically when both infection risk and significant inflammation are present, such as after eye surgery.\n\n6. How long should I use gatifloxacin and prednisolone acetate suspension?\nDuration is determined by your ophthalmologist based on your specific condition, often following a tapering schedule after surgery. It should not be used longer than prescribed, and stopping should be discussed with your doctor rather than done abruptly.\n\n7. Can this eye drop increase eye pressure?\nYes, because it contains a steroid, prolonged or unsupervised use can raise intraocular pressure. Regular monitoring is recommended, especially with extended use or in patients with a history of glaucoma.\n\n8. Can I use this suspension for a common bacterial eye infection without inflammation?\nThis combination is generally reserved for cases where both infection risk and notable inflammation are present, such as post-surgical care. For uncomplicated bacterial conjunctivitis without significant inflammation, your doctor may prescribe an antibiotic-only formulation instead.\n\n9. Do I need to shake the bottle before use?\nYes. This is a suspension, so the bottle should be shaken well before each use to ensure even distribution of both active ingredients.\n10. Can this eye drop be used for viral or fungal eye infections?\nNo. This combination is not appropriate for viral, fungal, or mycobacterial eye infections, since it contains a steroid that can worsen these conditions if used inappropriately.\n\n11. What are the signs I should stop using this eye drop and see my doctor?\nIncreasing eye pain, blurred vision that doesn't improve, halos around lights, worsening redness, or signs of an allergic reaction warrant immediate medical attention.\n\n12. Can this eye drop be used after cataract surgery?\nYes, this combination is commonly prescribed after cataract surgery to manage post-operative inflammation while covering the risk of surgical-site infection during the healing period.\n\n13. Does this medication require a prescription?\nYes, gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription-only (Schedule H) medicine and should only be used under an ophthalmologist's direction.\n14. Can contact lenses be worn during treatment?\nIt is generally advised to avoid wearing contact lenses while using this medication unless your ophthalmologist specifically advises otherwise, particularly during the post-surgical period.\n\n15. What happens if I stop this eye drop too early?\nStopping too early, especially without proper tapering, may lead to a rebound of inflammation or leave a lingering infection insufficiently treated. Always follow your doctor's full course and tapering instructions.\n\n16. Is this eye drop safe for long-term daily use?\nNo — because it contains a steroid, it is intended for short-term, supervised use rather than long-term daily use. Extended use significantly raises the risk of elevated eye pressure and cataract.\n\n17. Can this suspension be used in both eyes at once?\nIt can be used in both eyes if both are affected and your doctor has prescribed it for bilateral use; otherwise, apply only to the eye(s) specifically directed by your ophthalmologist.\n", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2469, "imageuri": "https://productimages.withfloats.com/actual/6a509bf79c2198e9ddf06962.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a509bf79c2198e9ddf06962.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T07:15:02.084Z", "updatedon": "2026-07-10T07:15:02.084Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gatifloxacin-prednisolone-acetate-ophthalmic-suspension/2469", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION GATIPRED", "category": "Opthalmology Range", "tags": [ "gatifloxacin & prednisolone acetate ophthalmic suspension", "gatifloxacin & prednisolone ophthalmic suspension" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69662101a96bbf383231d700", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FABRICAL MG K₂7", "description": "FABRICAL MG K₂7 represents a scientifically advanced nutritional supplement that combines essential minerals and vitamins in a synergistic formulation designed to support optimal bone health, cardiovascular function, and overall metabolic wellness. This innovative product brings together six critical nutrients—Calcium Citrate Maleate, Magnesium Bisglycinate, Vitamin D3, Vitamin K2-7 (Menaquinone-7), Zinc, and Methylcobalamin—in precise therapeutic ratios that maximize bioavailability and clinical effectiveness.\nUnlike conventional calcium supplements that focus solely on calcium supplementation, FABRICAL MG K₂7 adopts a comprehensive, multi-nutrient approach that addresses the complex interplay between various micronutrients essential for skeletal integrity, neuromuscular function, immune competence, and metabolic regulation. This sophisticated formulation reflects current understanding of nutritional biochemistry, recognizing that optimal health outcomes require balanced supplementation rather than isolated nutrient provision.\nThe product has been meticulously formulated to address the growing epidemic of nutritional deficiencies affecting diverse populations, from elderly individuals experiencing age-related bone loss to young adults with suboptimal dietary intake, pregnant women with increased nutritional demands, and individuals with chronic conditions affecting nutrient absorption or utilization. FABRICAL MG K₂7 serves as a convenient, evidence-based solution for maintaining nutritional adequacy and supporting long-term health across various life stages.\nDetailed Understanding of FABRICAL MG K₂7 Components\nCalcium Citrate Maleate: Superior Calcium Bioavailability\nCalcium Citrate Maleate represents the premium form of calcium supplementation, offering significantly enhanced absorption compared to traditional calcium carbonate. This advanced calcium complex demonstrates approximately 25-30% better bioavailability, making it particularly valuable for individuals with reduced gastric acid production, including elderly populations and those taking proton pump inhibitors or H2-receptor antagonists. Unlike calcium carbonate, which requires acidic conditions for optimal dissolution, Calcium Citrate Maleate can be absorbed efficiently regardless of meal timing or stomach pH, providing greater flexibility and convenience.\nThe maleate component further enhances calcium absorption and utilization by supporting cellular energy metabolism and mitochondrial function. This sophisticated formulation ensures that supplemented calcium reaches target tissues—bones, teeth, muscles, and nerves—where it performs essential physiological functions rather than accumulating in soft tissues where it could potentially contribute to unwanted calcification.\nMagnesium Bisglycinate: The Gentle Magnesium Choice\nMagnesium Bisglycinate, also known as magnesium glycinate, stands as one of the most bioavailable and well-tolerated forms of magnesium supplementation. This chelated form, where magnesium is bound to two molecules of the amino acid glycine, offers exceptional absorption rates approaching 80-90% while minimizing the gastrointestinal side effects—particularly diarrhea—commonly associated with other magnesium forms like magnesium oxide or sulfate.\nMagnesium plays over 300 enzymatic roles throughout the body, making it indispensable for energy production, protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Within FABRICAL MG K₂7, magnesium works synergistically with calcium, maintaining the critical calcium-magnesium balance essential for proper muscular contraction and relaxation, cardiovascular rhythm stability, and skeletal mineralization.\nVitamin D3: The Sunshine Vitamin in Its Active Form\nVitamin D3 (cholecalciferol) represents the most bioactive form of vitamin D, identical to what human skin synthesizes upon ultraviolet B exposure. This fat-soluble vitamin functions more accurately as a hormone, regulating calcium absorption from the intestines, maintaining serum calcium and phosphorus concentrations within optimal ranges, and modulating bone remodeling by both osteoblasts and osteoclasts.\nBeyond skeletal functions, Vitamin D3 exerts profound influences on immune system regulation, cellular differentiation and proliferation, neuromuscular function, and inflammation modulation. Vitamin D receptors exist throughout the body—in tissues ranging from the brain and heart to immune cells and muscle—highlighting its systemic importance. The inclusion of Vitamin D3 in FABRICAL MG K₂7 ensures that supplemented calcium can be effectively absorbed and utilized, preventing the futility of calcium supplementation in vitamin D-deficient states.\nVitamin K2-7: The Missing Link in Bone and Cardiovascular Health\nVitamin K2-7, specifically the menaquinone-7 (MK-7) form, represents perhaps the most revolutionary component of FABRICAL MG K₂7. This long-chain vitamin K2 demonstrates superior bioavailability and longer half-life compared to vitamin K1 (phylloquinone) found in green vegetables or shorter-chain K2 forms. Vitamin K2-7's critical function involves activating proteins responsible for proper calcium utilization—specifically matrix Gla protein (MGP) and osteocalcin.\nOsteocalcin, produced by bone-building osteoblasts, requires vitamin K2-dependent carboxylation to become active and effectively bind calcium into bone matrix, strengthening skeletal structure. Simultaneously, Vitamin K2-7 activates MGP, which prevents calcium deposition in arterial walls and soft tissues, directing calcium away from cardiovascular structures where it contributes to atherosclerosis and arterial stiffness. This dual action—promoting bone calcification while preventing vascular calcification—makes Vitamin K2-7 uniquely valuable, addressing the “calcium paradox” where individuals may simultaneously experience osteoporosis and arterial calcification.\nZinc: The Multifunctional Essential Mineral\nZinc, incorporated into FABRICAL MG K₂7 in highly bioavailable form, serves numerous critical physiological functions spanning immune competence, wound healing, protein synthesis, DNA synthesis, and cellular division. Regarding bone health specifically, zinc influences bone metabolism by supporting osteoblast activity and collagen synthesis, contributing to bone matrix formation and mineralization. Zinc also functions as a cofactor for alkaline phosphatase, an enzyme essential for bone mineralization.\nBeyond skeletal contributions, zinc supports immune system function, acting as a critical component of innumerable enzymes involved in immune cell development and function. Zinc deficiency impairs both innate and adaptive immunity, increasing susceptibility to infections. The mineral also supports sensory function (taste and smell), cognitive function, reproductive health, and skin integrity.\nMethylcobalamin: The Bioactive Vitamin B12\nMethylcobalamin represents the active, coenzyme form of vitamin B12, requiring no metabolic conversion to exert biological activity. This form demonstrates superior neurological benefits compared to cyanocobalamin, the synthetic form commonly used in supplements. Methylcobalamin directly participates in methionine synthesis and methylation reactions critical for nervous system health, DNA synthesis, red blood cell formation, and homocysteine metabolism.\nElevated homocysteine, resulting from inadequate B12 status, associates with increased cardiovascular disease risk, cognitive decline, and bone fragility. By supporting homocysteine conversion to methionine, methylcobalamin in FABRICAL MG K₂7 contributes to cardiovascular protection and potentially supports bone health through mechanisms independent of its well-established neurological and hematological roles.\nPrimary Uses and Clinical Applications of FABRICAL MG K₂7\nComprehensive Bone Health Support\nThe primary indication for FABRICAL MG K₂7 centers on comprehensive bone health support across various life stages and clinical scenarios. The formulation addresses all critical aspects of skeletal health: providing adequate calcium substrate for mineralization, ensuring calcium absorption through Vitamin D3, directing calcium into bone matrix via Vitamin K2-7, supporting bone matrix formation through magnesium and zinc, and protecting against homocysteine-related bone fragility through methylcobalamin.\nThis makes FABRICAL MG K₂7 particularly valuable for:\nOsteoporosis Prevention and Management: Postmenopausal women and elderly men experiencing age-related bone loss benefit from the formulation's comprehensive approach, potentially slowing bone density decline and reducing fracture risk.\nGrowing Children and Adolescents: During peak bone-building years, FABRICAL MG K₂7 supports optimal skeletal development, helping children and teenagers achieve maximum peak bone mass—a critical determinant of lifelong skeletal health.\nPregnancy and Lactation: Women during pregnancy and breastfeeding experience dramatically increased calcium demands. FABRICAL MG K₂7 helps prevent maternal bone density loss while supporting fetal skeletal development.\nCardiovascular Protection Through Proper Calcium Distribution\nThe Vitamin K2-7 component positions FABRICAL MG K₂7 as more than a bone health supplement—it's a cardiovascular protective formulation. By activating matrix Gla protein, the supplement helps prevent arterial calcification, potentially reducing cardiovascular disease risk. This dual benefit addresses the concerning observation that some individuals taking calcium supplements without adequate Vitamin K2 may experience increased cardiovascular events due to inappropriate calcium deposition in arterial walls.\nNeurological and Cognitive Support\nThe methylcobalamin component provides neurological support, particularly valuable for elderly individuals at risk for vitamin B12 deficiency due to reduced intrinsic factor production or those taking medications that impair B12 absorption (such as metformin or proton pump inhibitors). Adequate B12 status supports cognitive function, mood regulation, nerve conduction, and may help prevent peripheral neuropathy.\nImmune System Enhancement\nBoth zinc and vitamin D3 within FABRICAL MG K₂7 contribute significantly to immune competence. Vitamin D modulates both innate and adaptive immunity, while zinc supports immune cell development and function. This immune support proves particularly relevant during seasonal illness peaks or for individuals with compromised immunity.\nMuscle Function and Exercise Performance\nMagnesium's role in muscle contraction and relaxation, combined with calcium's involvement in excitation-contraction coupling, makes FABRICAL MG K₂7 valuable for athletes and physically active individuals. The formulation may help prevent exercise-associated muscle cramps, support recovery, and maintain electrolyte balance.\nKey Benefits of FABRICAL MG K₂7\nEnhanced Bioavailability and Absorption\nUnlike basic supplements using inferior ingredient forms, FABRICAL MG K₂7 utilizes premium, highly bioavailable compounds:\n\nCalcium Citrate Maleate offers superior absorption compared to calcium carbonate\nMagnesium Bisglycinate provides excellent absorption without gastrointestinal distress\nVitamin D3 is more potent than D2\nVitamin K2-7 (MK-7) has longer half-life and better tissue distribution than K1 or shorter-chain K2 forms\nMethylcobalamin is the active B12 form requiring no conversion\n\nThis superior bioavailability means lower doses can achieve therapeutic effects, reducing pill burden and potential adverse effects while maximizing benefits.\nSynergistic Nutrient Interactions\nFABRICAL MG K₂7's formulation recognizes that nutrients work together, not in isolation:\n\nVitamin D3 enhances calcium absorption while Vitamin K2-7 directs where that calcium goes\nMagnesium supports Vitamin D activation and calcium metabolism\nZinc supports bone matrix formation complementing calcium's role in mineralization\nMethylcobalamin supports methylation pathways that may influence bone health\n\nThis synergy delivers benefits exceeding what individual nutrients could provide separately.\nComprehensive Rather Than Fragmented Nutritional Support\nRather than requiring multiple separate supplements, FABRICAL MG K₂7 provides comprehensive support in a single, convenient formulation. This simplification improves compliance, reduces costs compared to purchasing individual supplements, and eliminates concerns about nutrient imbalances from uncoordinated supplementation.\nProtection Against the Calcium Paradox\nPerhaps the most significant benefit stems from the Vitamin K2-7 inclusion, which addresses the calcium paradox—simultaneously strengthening bones while protecting cardiovascular health by preventing arterial calcification. This represents a critical advancement over traditional calcium supplements that may inadvertently increase cardiovascular risk when taken without adequate Vitamin K2.\nSupport Across Multiple Physiological Systems\nBeyond bones, FABRICAL MG K₂7 benefits:\n\nCardiovascular System: Through arterial protection and homocysteine management\nNervous System: Via methylcobalamin's neurological support\nImmune System: Through vitamin D3 and zinc's immunomodulatory effects\nMuscular System: Via magnesium and calcium's roles in contraction\nMetabolic System: Through magnesium's involvement in glucose metabolism\n\nThis multi-system support delivers value far exceeding simple bone health supplementation.\nPotential Side Effects and Safety Considerations\nGenerally Well-Tolerated with Minimal Side Effects\nFABRICAL MG K₂7, when taken as directed, demonstrates excellent tolerability in most individuals. The selection of highly bioavailable, gentle nutrient forms specifically minimizes adverse effects common with inferior formulations.\nMild Gastrointestinal Effects\nSome users may initially experience mild digestive symptoms including:\n\nSlight nausea, particularly if taken on an empty stomach\nMinor bloating or gas\nMild constipation (though less likely than with calcium carbonate formulations)\n\nThese effects typically resolve within a few days as the body adjusts and can be minimized by taking the supplement with meals and ensuring adequate hydration.\nRare Allergic Reactions\nAlthough uncommon, some individuals may experience hypersensitivity to ingredients or excipients in the formulation. Signs include rash, itching, or swelling. Discontinuation and medical consultation are warranted if such reactions occur.\nConsiderations for Specific Populations\nIndividuals on Anticoagulants: Vitamin K2, while generally safer regarding coagulation than K1, may theoretically interact with warfarin. Patients on anticoagulation therapy should consult healthcare providers before starting FABRICAL MG K₂7, though recent evidence suggests K2 supplementation at consistent doses may not significantly affect INR stability.\nKidney Disease Patients: Individuals with chronic kidney disease should consult nephrologists before supplementing with calcium, magnesium, or vitamin D due to altered mineral metabolism and increased calcification risks in renal impairment.\nHypercalcemia Risk: Those with conditions predisposing to elevated calcium (hyperparathyroidism, sarcoidosis, certain cancers) should avoid supplementation without medical supervision.\nImportance of Appropriate Dosing\nExceeding recommended doses may increase adverse effect risks including:\n\nHypercalcemia (excessive calcium) causing nausea, constipation, kidney stones\nHypermagnesemia (excessive magnesium) causing diarrhea, cardiac abnormalities\nVitamin D toxicity (though requiring very high doses sustained over time)\n\nFollowing manufacturer's recommendations and consulting healthcare providers regarding individual needs ensures safe, effective use.\nRecommended Usage and Dosage Guidelines\nFABRICAL MG K₂7 should be taken according to manufacturer recommendations, typically one to two tablets daily with meals for optimal absorption of fat-soluble vitamins (D3 and K2-7). Taking the supplement with food containing some dietary fat further enhances absorption of these critical nutrients while minimizing potential gastrointestinal discomfort.\nConsistency in timing supports optimal benefits, as regular daily supplementation maintains stable nutrient levels. For individuals on multiple medications, spacing FABRICAL MG K₂7 administration at least two hours from certain medications (particularly thyroid hormones, bisphosphonates, or antibiotics) prevents potential absorption interference.\nIndividual requirements vary based on age, sex, dietary intake, health status, and specific deficiency risks. Healthcare provider consultation helps determine whether standard dosing suffices or whether adjustments are warranted. Periodic monitoring of vitamin D levels and other relevant biomarkers may be recommended to ensure supplementation achieves therapeutic goals without overshooting into excess.\nConclusion: FABRICAL MG K₂7 as a Comprehensive Nutritional Solution\nFABRICAL MG K₂7 stands as a sophisticated, scientifically formulated nutritional supplement that transcends traditional approaches to bone health support. By combining six synergistic nutrients in highly bioavailable forms, this innovative product addresses the complex, interconnected nature of skeletal health, cardiovascular protection, neurological function, and overall metabolic wellness.\nThe formulation's greatest strength lies in its comprehensive approach—recognizing that optimal health outcomes require balanced nutrition rather than isolated nutrient provision. The inclusion of Vitamin K2-7 particularly distinguishes FABRICAL MG K₂7 from conventional calcium supplements, addressing the critical calcium paradox and ensuring supplemented calcium strengthens bones while protecting cardiovascular structures.\nFor individuals seeking to support bone density, prevent osteoporosis, ensure adequate nutritional status during life stages of increased demand, or simply maintain optimal health through evidence-based supplementation, FABRICAL MG K₂7 offers a convenient, effective solution backed by nutritional science. Its excellent tolerability, superior ingredient quality, and multi-system benefits make it suitable for diverse populations from growing adolescents to active adults and elderly individuals concerned about age-related health challenges.\nAs with any nutritional supplement, FABRICAL MG K₂7 works best as part of a comprehensive health strategy including balanced nutrition, regular physical activity, adequate sleep, stress management, and appropriate medical care. It complements rather than replaces healthy lifestyle practices, providing nutritional insurance that helps fill gaps in modern diets while supporting long-term wellness.\nWhether you're proactively supporting your skeletal health, addressing identified nutritional deficiencies, or seeking comprehensive multi-nutrient support, FABRICAL MG K₂7 represents a premium choice that combines scientific sophistication with practical convenience, delivering measurable benefits that support vibrant health across all life stages.\n\nDisclaimer: This information is for educational purposes and does not constitute medical advice. Individual nutritional needs vary significantly based on numerous factors. Consult qualified healthcare professionals before starting any supplement regimen, particularly if you have existing health conditions, take medications, are pregnant or nursing, or have specific health concerns. Keep supplements out of reach of children and store according to manufacturer recommendations to maintain product integrity and safety.", "price": 250.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2274, "imageuri": "https://productimages.withfloats.com/actual/696621081f531945cbd90a0c.png", "tileimageuri": "https://productimages.withfloats.com/tile/696621081f531945cbd90a0c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-13T10:40:01.051Z", "updatedon": "2026-06-09T10:20:10.642Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fabrical-mg-k-7/2274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FABRICAL MG K₂7", "category": "ORTHOLOGYRANG", "tags": [ "calcium citrate maleate magnesium bisglycinate tablets", "calcium citrate maleate with vitamin d3 k2 mk7", "magnesium bisglycinate with methylcobalamin tablets", "calcium citrate maleate vitamin k2-7 tablets", "best calcium citrate maleate tablets for bones", "magnesium bisglycinate tablets for muscle cramps", "methylcobalamin zinc tablets for nerve health", "calcium citrate maleate tablets for osteoporosis", "best calcium supplement with k2-7 for bone strength", "vitamin k2-7 mk7 with calcium benefits", "bone strength tablets with calcium magnesium zinc", "vitamin d3 k2 calcium tablets for elderly", "calcium citrate maleate tablets price in india", "best calcium magnesium vitamin d3 k2 tablets", "best bone health tablets with vitamin k2-7", "calcium magnesium zinc methylcobalamin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694d14f6274fc8b97e9b7120", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mirtazapine 30mg", "description": "MIRTAZPRIME 30 is a pharmaceutical formulation containing Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards. This prescription medication belongs to a class of drugs known as tetracyclic antidepressants and represents an advanced therapeutic option for individuals struggling with major depressive disorder and related mental health conditions. Manufactured under stringent quality control measures, MIRTAZPRIME 30 offers patients a reliable and effective solution for managing depression while also addressing associated symptoms such as insomnia and anxiety.\nMirtazapine, the active pharmaceutical ingredient in MIRTAZPRIME 30, works through a unique dual mechanism that distinguishes it from other antidepressants. Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine enhances the release of both norepinephrine and serotonin in the brain by blocking specific receptors. This innovative approach not only helps alleviate depressive symptoms but also provides sedative effects that can be particularly beneficial for patients experiencing sleep disturbances alongside depression.\nTherapeutic Uses and Applications\nMIRTAZPRIME 30 is primarily indicated for the treatment of major depressive disorder (MDD), a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. The medication has demonstrated significant efficacy in clinical trials, showing improvement in mood, energy levels, and overall quality of life for patients suffering from depression.\nBeyond its primary indication, healthcare providers may prescribe MIRTAZPRIME 30 for various off-label uses based on clinical judgment and patient needs. The medication has shown promise in managing generalized anxiety disorder, where excessive worry and tension interfere with daily functioning. Its sedative properties make it particularly valuable for patients experiencing insomnia related to depression or anxiety, as it can help restore healthy sleep patterns without the need for additional sleep medications.\nThe 30mg dosage strength represents a therapeutic level commonly prescribed for maintenance treatment after initial dose titration. Patients typically begin with lower doses and gradually increase to 30mg as their body adjusts to the medication and their symptoms require more robust management. This dosage provides an optimal balance between therapeutic efficacy and side effect management for many individuals.\nMIRTAZPRIME 30 may also be considered for patients who have not responded adequately to other antidepressant therapies, offering an alternative mechanism of action that can break through treatment-resistant depression. Additionally, its appetite-stimulating effects can be beneficial for patients experiencing significant weight loss due to depression or other medical conditions.\nKey Benefits and Therapeutic Advantages\nThe benefits of MIRTAZPRIME 30 extend beyond simple symptom relief, offering patients a multifaceted approach to mental health recovery. One of the most significant advantages is its relatively rapid onset of action compared to many other antidepressants. While most SSRIs require several weeks to demonstrate meaningful clinical improvement, patients taking mirtazapine often experience some relief from symptoms within one to two weeks, with continued improvement over subsequent weeks.\nThe dual neurotransmitter action of MIRTAZPRIME 30 provides comprehensive coverage of depressive symptoms. By enhancing both serotonergic and noradrenergic neurotransmission, the medication addresses the complex neurochemical imbalances underlying depression more thoroughly than single-mechanism antidepressants. This broader action can result in more complete symptom resolution and better overall outcomes.\nSleep improvement represents another crucial benefit of MIRTAZPRIME 30. The medication's sedative properties, particularly pronounced at lower doses, help patients fall asleep faster and enjoy more restorative sleep throughout the night. This is especially valuable since sleep disturbances are both a symptom and an exacerbating factor in depression. Better sleep quality contributes to improved daytime functioning, energy levels, and emotional regulation.\nUnlike many antidepressants that commonly cause sexual dysfunction, MIRTAZPRIME 30 has a relatively favorable profile in this regard. The medication is less likely to interfere with sexual function, making it an attractive option for patients who have experienced these troublesome side effects with other antidepressants. This characteristic can significantly improve treatment adherence and quality of life.\nThe appetite-stimulating effect, while considered a side effect by some, can be therapeutically beneficial for patients experiencing significant weight loss or poor appetite due to depression. MIRTAZPRIME 30 can help restore healthy eating patterns and reverse the physical decline that often accompanies severe depressive episodes.\nFurthermore, MIRTAZPRIME 30 does not typically cause the gastrointestinal side effects commonly associated with SSRI antidepressants, such as nausea, diarrhea, or stomach upset. This improved gastrointestinal tolerability enhances patient comfort and compliance with treatment regimens.\nPotential Side Effects and Safety Considerations\nWhile MIRTAZPRIME 30 offers numerous therapeutic benefits, patients should be aware of potential side effects that may occur during treatment. Understanding these effects helps patients make informed decisions and enables early identification of any concerning symptoms requiring medical attention.\nThe most commonly reported side effect is drowsiness or sedation, particularly during the initial weeks of treatment. This effect is typically most pronounced during the first few hours after taking the medication, which is why it's generally recommended for evening administration. Patients should exercise caution when driving, operating machinery, or engaging in activities requiring alertness until they understand how the medication affects them personally.\nIncreased appetite and weight gain represent another frequent side effect of MIRTAZPRIME 30. While beneficial for some patients, others may find this effect undesirable. Weight gain typically ranges from moderate to significant and appears to be dose-related. Patients concerned about weight should discuss dietary strategies and exercise plans with their healthcare provider.\nDry mouth is a common anticholinergic side effect that can cause discomfort but is generally manageable through increased fluid intake, sugar-free gum or candy, and good oral hygiene practices. Some patients may also experience dizziness, particularly when standing up quickly, due to the medication's effects on blood pressure regulation.\nConstipation may occur in some patients and can usually be managed through dietary modifications, increased fiber intake, adequate hydration, and regular physical activity. Less commonly, patients might experience confusion, abnormal dreams, or changes in thinking, particularly in older adults who may be more sensitive to the medication's effects.\nSerious side effects, while rare, require immediate medical attention. These include signs of allergic reactions such as rash, itching, swelling, severe dizziness, or difficulty breathing. Agranulocytosis, a dangerous decrease in white blood cells, is an extremely rare but serious complication that manifests as fever, sore throat, or signs of infection. Any unexplained fever or signs of infection should prompt immediate contact with a healthcare provider.\nSerotonin syndrome is another rare but potentially life-threatening condition that can occur when mirtazapine is combined with other medications affecting serotonin levels. Symptoms include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, muscle stiffness, or coordination problems. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid dangerous interactions.\nAbrupt discontinuation of MIRTAZPRIME 30 can lead to withdrawal symptoms, including nausea, anxiety, irritability, and flu-like symptoms. Therefore, any decision to stop the medication should be made in consultation with a healthcare provider who can develop an appropriate tapering schedule.\nImportant Usage Guidelines\nMIRTAZPRIME 30 should always be taken exactly as prescribed by a qualified healthcare professional. The medication is typically administered once daily, preferably in the evening before bedtime due to its sedative effects. Tablets should be swallowed whole with water and can be taken with or without food, though taking them with food may help reduce any stomach upset.\nConsistency in timing is important for maintaining stable blood levels of the medication and optimizing therapeutic effects. Patients should try to take their dose at approximately the same time each evening. If a dose is missed, it should be taken as soon as remembered unless it's close to the time for the next scheduled dose, in which case the missed dose should be skipped rather than doubling up.\nThe full therapeutic benefits of MIRTAZPRIME 30 may take several weeks to manifest. Patients should continue taking the medication as prescribed even if they don't feel immediate improvement. Premature discontinuation is a common reason for treatment failure in depression management.\nRegular follow-up appointments with the prescribing physician are essential for monitoring treatment response, adjusting dosages if necessary, and screening for potential side effects. Patients should maintain open communication with their healthcare team about their symptoms, concerns, and any changes in their condition.\nConclusion\nMIRTAZPRIME 30 represents a valuable therapeutic option in the comprehensive management of major depressive disorder and related conditions. Its unique mechanism of action, combining enhanced noradrenergic and serotonergic neurotransmission with sedative and appetite-stimulating properties, offers distinct advantages for carefully selected patients. The medication's ability to improve both mood symptoms and sleep disturbances makes it particularly useful for patients experiencing depression accompanied by insomnia.\nThe relatively favorable side effect profile, particularly regarding sexual function and gastrointestinal tolerability, enhances patient acceptance and adherence to treatment. While potential side effects such as sedation, increased appetite, and weight gain require monitoring and management, many patients find these effects tolerable compared to the debilitating symptoms of untreated depression.\nSuccess with MIRTAZPRIME 30, as with any antidepressant therapy, depends on proper patient selection, appropriate dosing, regular monitoring, and a comprehensive treatment approach that may include psychotherapy, lifestyle modifications, and social support alongside pharmacological intervention. Patients should work closely with their healthcare providers to optimize treatment outcomes and maintain long-term mental health wellness.\nThe decision to use MIRTAZPRIME 30 should always be made collaboratively between patient and physician, considering individual symptoms, treatment history, coexisting medical conditions, and personal preferences. With proper use under medical supervision, MIRTAZPRIME 30 can be an effective tool in helping patients reclaim their lives from the devastating effects of depression and move toward recovery and renewed well-being.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2254, "imageuri": "https://productimages.withfloats.com/actual/694d14f83d39ca31a28d046b.png", "tileimageuri": "https://productimages.withfloats.com/tile/694d14f83d39ca31a28d046b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T10:41:58.966Z", "updatedon": "2026-03-13T07:46:51.004Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mirtazapine-30mg/2254", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 30", "category": "NEUROLOGYRANGE", "tags": [ "MIRTAZPRIME 30", "Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards", "managing depression", "insomnia and anxiety.", "depression or anxiety.", "depredepressive episodes.", "helping patients reclaim their lives from the devastating effects of depression." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694cf85408591c1173b54c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pregabalin Epalrestat and Methylcobalamin Tablets", "description": "EPSTATE ED represents an advanced pharmaceutical formulation that combines three powerful therapeutic agents: Pregabalin, Epalrestat, and Methylcobalamin. This innovative triple-combination medication is specifically designed to address the complex pathophysiology of diabetic neuropathy and neuropathic pain conditions. By integrating multiple mechanisms of action, EPSTATE ED offers a comprehensive approach to managing nerve-related complications that significantly impact the quality of life for millions of individuals worldwide.\nThe formulation addresses not only the symptomatic relief of neuropathic pain but also targets the underlying metabolic derangements that contribute to nerve damage progression. This multi-pronged therapeutic strategy makes EPSTATE ED particularly valuable for patients who require more than symptomatic management alone.\nUnderstanding the Active Components\nPregabalin: The Neuropathic Pain Modulator\nPregabalin serves as the cornerstone analgesic component in EPSTATE ED. This anticonvulsant medication works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Through this mechanism, Pregabalin reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. This reduction in neurotransmitter release effectively dampens the abnormal neural signaling that characterizes neuropathic pain conditions.\nThe molecule demonstrates excellent bioavailability and rapid absorption, allowing patients to experience relief within a relatively short timeframe. Its efficacy in managing various neuropathic pain syndromes has been extensively documented in clinical trials, establishing it as a first-line agent for diabetic peripheral neuropathy, postherpetic neuralgia, and other chronic neuropathic pain conditions.\nEpalrestat: The Aldose Reductase Inhibitor\nEpalrestat represents a unique addition to the formulation, functioning as a selective aldose reductase inhibitor. In diabetic conditions, excess glucose is converted to sorbitol through the polyol pathway, with aldose reductase serving as the rate-limiting enzyme. The accumulation of sorbitol within nerve cells leads to osmotic stress, depletion of myoinositol, and subsequent nerve dysfunction.\nBy inhibiting aldose reductase, Epalrestat prevents this harmful sorbitol accumulation, thereby addressing one of the fundamental metabolic abnormalities responsible for diabetic neuropathy. This disease-modifying approach distinguishes EPSTATE ED from purely symptomatic treatments. Epalrestat has been particularly well-studied in Asian populations and has demonstrated the ability to improve nerve conduction velocities and reduce subjective neuropathic symptoms over time.\nMethylcobalamin: The Neurotropic Vitamin\nMethylcobalamin, the bioactive form of Vitamin B12, completes the therapeutic triad in EPSTATE ED. Unlike cyanocobalamin, which requires conversion in the body, methylcobalamin is immediately available for utilization in crucial biochemical processes. It plays an indispensable role in myelin synthesis, the protective sheath surrounding nerve fibers that enables proper signal transmission.\nThis coenzyme participates in methionine synthesis and is essential for maintaining the structural and functional integrity of neurons. Methylcobalamin also facilitates nerve regeneration and has demonstrated neuroprotective properties in various experimental models. For patients with diabetic neuropathy, who often exhibit Vitamin B12 deficiency (sometimes exacerbated by metformin therapy), supplementation with methylcobalamin addresses both nutritional deficits and supports nerve health at a fundamental level.\nClinical Applications and Uses\nEPSTATE ED is primarily indicated for the comprehensive management of diabetic peripheral neuropathy, a condition affecting approximately 50% of individuals with long-standing diabetes. The symptoms of this condition range from tingling sensations and burning pain to numbness and loss of protective sensation, which can lead to serious complications including foot ulcers and amputations.\nBeyond diabetic neuropathy, EPSTATE ED may be prescribed for various neuropathic pain syndromes where the combination of pain relief, metabolic correction, and nerve support proves beneficial. Patients experiencing chronic nerve pain resulting from metabolic disturbances, nutritional deficiencies, or structural nerve damage may find this combination particularly effective.\nThe medication is typically recommended for adults who have not achieved adequate symptom control with single-agent therapy or who would benefit from the synergistic effects of the three components. Healthcare providers may prescribe EPSTATE ED when a patient requires both immediate symptom relief and long-term disease modification.\nKey Benefits and Therapeutic Advantages\nComprehensive Multi-Mechanism Action\nThe primary advantage of EPSTATE ED lies in its multi-faceted approach to neuropathic conditions. Rather than addressing only pain symptoms, the formulation simultaneously tackles pain perception, underlying metabolic abnormalities, and nutritional support for nerve health. This comprehensive strategy may lead to superior outcomes compared to monotherapy approaches.\nEnhanced Pain Relief\nClinical evidence supporting Pregabalin's efficacy in neuropathic pain is substantial. Patients often report significant reductions in pain intensity, improved sleep quality due to decreased nocturnal pain, and enhanced ability to perform daily activities. The pain-relieving effects typically manifest within the first week of therapy and continue to improve with ongoing treatment.\nDisease Modification Potential\nUnlike purely symptomatic treatments, the inclusion of Epalrestat provides genuine disease-modifying potential. By targeting the polyol pathway, EPSTATE ED may slow the progression of nerve damage in diabetic patients. Long-term use may preserve nerve function and prevent the worsening of neuropathic symptoms, offering hope beyond mere symptom management.\nImproved Nerve Conduction and Function\nThe combination of metabolic correction through Epalrestat and neurotropic support via Methylcobalamin creates an environment conducive to nerve regeneration and functional improvement. Studies have demonstrated improvements in nerve conduction velocity parameters with similar combination therapies, suggesting potential restoration of nerve function rather than simple symptom masking.\nConvenience of Combination Therapy\nFor patients who would otherwise require multiple separate medications, EPSTATE ED offers the convenience of a single tablet containing all three therapeutic agents. This simplification of medication regimens improves compliance, reduces pill burden, and may enhance overall treatment outcomes.\nQuality of Life Enhancement\nThe cumulative effect of pain reduction, improved nerve function, and better metabolic control translates into meaningful quality of life improvements. Patients report better mobility, reduced interference of pain with daily activities, improved mood, and enhanced social functioning.\nPotential Side Effects and Safety Considerations\nCommon Side Effects\nAs with any pharmaceutical agent, EPSTATE ED may produce certain adverse effects. The most commonly reported side effects are primarily attributable to the Pregabalin component and include dizziness, somnolence, peripheral edema, dry mouth, blurred vision, weight gain, and difficulty with concentration or attention. These effects are generally mild to moderate and often diminish with continued therapy as the body adapts to the medication.\nGastrointestinal symptoms such as constipation or nausea may occur, though they are typically manageable with dietary modifications or symptomatic treatment. Some patients experience increased appetite leading to weight gain, which requires monitoring, particularly in diabetic individuals where weight management is crucial.\nSerious but Rare Adverse Events\nThough uncommon, certain serious adverse effects warrant immediate medical attention. These include allergic reactions manifesting as rash, itching, swelling, severe dizziness, or breathing difficulties. Pregabalin has been associated with rare cases of angioedema, which requires prompt discontinuation and medical intervention.\nMental health changes, including mood alterations, anxiety, depression, agitation, or suicidal thoughts, have been reported with Pregabalin use, particularly in individuals with pre-existing psychiatric conditions. Patients and caregivers should remain vigilant for behavioral changes and report them immediately to healthcare providers.\nDrug Interactions and Precautions\nEPSTATE ED may interact with other central nervous system depressants, including alcohol, opioids, benzodiazepines, and antihistamines, potentially intensifying sedation and cognitive impairment. Patients should inform their healthcare provider of all medications, supplements, and substances they consume.\nIndividuals with kidney impairment require dose adjustments since Pregabalin is primarily eliminated through renal excretion. Regular monitoring of renal function may be necessary during long-term therapy.\nSpecial Population Considerations\nPregnant or breastfeeding women should use EPSTATE ED only when clearly necessary and under strict medical supervision, as the safety profile in these populations has not been fully established. Elderly patients may be more susceptible to side effects, particularly dizziness and confusion, necessitating careful dose titration and monitoring.\nPatients should be advised against abrupt discontinuation of EPSTATE ED, as sudden cessation of Pregabalin may precipitate withdrawal symptoms including insomnia, nausea, headache, anxiety, and sweating. Gradual dose reduction under medical supervision is recommended when discontinuing therapy.\nDosage and Administration Guidelines\nThe appropriate dosage of EPSTATE ED is highly individualized and should be determined by a qualified healthcare professional based on the patient's specific condition, response to therapy, and tolerance. Typically, treatment begins with a lower dose that is gradually increased to achieve optimal therapeutic benefit while minimizing adverse effects.\nPatients should take EPSTATE ED exactly as prescribed, with or without food, at consistent times each day to maintain stable blood levels. Missing doses should be addressed by taking the forgotten dose as soon as remembered, unless it's nearly time for the next scheduled dose. Double dosing to compensate for missed doses is not recommended.\nRegular follow-up appointments allow healthcare providers to assess treatment efficacy, monitor for adverse effects, and make necessary dose adjustments. Patients should maintain open communication with their medical team regarding symptom improvement, side effects, and any concerns that arise during therapy.\nPatient Counseling and Lifestyle Recommendations\nMaximizing the benefits of EPSTATE ED extends beyond simply taking the medication. Patients should be counseled on complementary lifestyle measures that support neuropathy management. Maintaining optimal glycemic control remains paramount for diabetic patients, as blood sugar management directly impacts neuropathy progression regardless of medication.\nRegular physical activity, within individual capabilities, promotes circulation, supports nerve health, and may enhance the therapeutic effects of EPSTATE ED. Daily foot examinations become critical for diabetic patients to identify potential injuries early, preventing serious complications.\nNutritional optimization, including adequate intake of B vitamins, antioxidants, and essential nutrients, supports the neurotropic effects of Methylcobalamin. Avoiding alcohol and tobacco, both of which can exacerbate neuropathy, is strongly recommended.\nPatients should be cautioned about activities requiring alertness, such as driving or operating machinery, especially during the initial treatment phase when dizziness and somnolence may be more pronounced. These effects typically improve with continued therapy, but individual responses vary.\nConclusion\nEPSTATE ED represents a thoughtfully designed pharmaceutical formulation that addresses the multifaceted nature of diabetic neuropathy and neuropathic pain through its unique combination of Pregabalin, Epalrestat, and Methylcobalamin. This triple-action approach offers patients more than symptomatic relief—it provides genuine disease modification potential, nutritional support, and comprehensive nerve health optimization.\nThe synergistic effects of these three components create a therapeutic profile that is greater than the sum of its parts. While Pregabalin efficiently manages pain symptoms and improves quality of life in the short term, Epalrestat works to address underlying metabolic derangements that drive disease progression, and Methylcobalamin provides essential neurotropic support for nerve regeneration and function.\nFor patients struggling with the debilitating effects of neuropathic pain and diabetic neuropathy, EPSTATE ED offers renewed hope for better symptom control and potentially slowed disease progression. The convenience of combination therapy in a single tablet improves adherence and simplifies complex treatment regimens.\nHowever, EPSTATE ED is not without considerations. Potential side effects, though generally manageable, require awareness and monitoring. The medication is most effective when integrated into a comprehensive management plan that includes optimal glycemic control, lifestyle modifications, and regular medical supervision.\nUltimately, EPSTATE ED should be viewed as a valuable tool in the therapeutic arsenal against neuropathic conditions, best utilized under the guidance of knowledgeable healthcare professionals who can individualize treatment to each patient's unique needs and circumstances. With proper use, monitoring, and patient education, EPSTATE ED can significantly improve outcomes and quality of life for those affected by these challenging neurological conditions.", "price": 275.0, "discountamount": 82.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2253, "imageuri": "https://productimages.withfloats.com/actual/694cf859d25fa0b0657b1ac8.png", "tileimageuri": "https://productimages.withfloats.com/tile/694cf859d25fa0b0657b1ac8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T08:39:48.947Z", "updatedon": "2026-04-18T09:21:49.885Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pregabalin-epalrestat-and-methylcobalamin-tablets/2253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE ED", "category": "NEUROLOGYRANGE", "tags": [ "regabalin, Epalrestat, and Methylcobalamin.neuropathic pain conditions.", "Pregabalin, Epalrestat, and Methylcobalamin.", "neuropathic pain.", "diabetic neuropathy.", "sorbitol within nerve cells leads to osmotic stress.", "Epalrestat and neurotropic support via Methylcobalamin creates an environment .", "mood alterations, anxiety, depression, agitation.", "supports the neurotropic effects of Methylcobalamin.", "Pregabalin Epalrestat and Methylcobalamin Tablets", "epalrestat and methylcobalamin tablets uses", "epalrestat and methylcobalamin tablets in hindi", "pregabalin epalrestat and methylcobalamin tablets price jaipur", "pregabalin epalrestat and methylcobalamin tablets price india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }